Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors-Reference-Cited by-同舟云学术

Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors

Published:2014-10-27 Issue:45 Volume:111 Page:E4869-E4877
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proc Natl Acad Sci USA

Author:

Tan Li,Wang Jun,Tanizaki Junko,Huang Zhifeng,Aref Amir R.,Rusan Maria,Zhu Su-Jie,Zhang Yiyun,Ercan Dalia,Liao Rachel G.,Capelletti Marzia,Zhou Wenjun,Hur Wooyoung,Kim NamDoo,Sim Taebo,Gaudet Suzanne,Barbie David A.,Yeh Jing-Ruey Joanna,Yun Cai-Hong,Hammerman Peter S.,Mohammadi Moosa,Jänne Pasi A.,Gray Nathanael S.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference95 articles.

1. Nilotinib: A second-generation tyrosine kinase inhibitor for chronic myeloid leukemia

2. Inhibition of wild-type and mutant Bcr-Abl by AP23464, a potent ATP-based oncogenic protein kinase inhibitor: implications for CML

3. Target Binding Properties and Cellular Activity of Afatinib (BIBW 2992), an Irreversible ErbB Family Blocker

4. Novel mutant-selective EGFR kinase inhibitors against EGFR T790M

5. Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancers

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in covalent drug discovery: a 2020–23 patent landscape analysis focused on select covalent reacting groups (CRGs) found in FDA-approved drugs;Expert Opinion on Therapeutic Patents;2024-09-11

2. Design, synthesis and biological evaluation of 5-amino-1H-pyrazole-4-carboxamide derivatives as pan-FGFR covalent inhibitors;European Journal of Medicinal Chemistry;2024-09

3. Computational biophysical characterization of the effect of gatekeeper mutations on the binding of ponatinib to the FGFR kinase;Archives of Biochemistry and Biophysics;2024-08

4. Systematic Targeting of Protein Complexes with Molecular COUPLrs;2024-07-18

5. Targeting FGFR for cancer therapy;Journal of Hematology & Oncology;2024-06-03